tiprankstipranks
Trending News
More News >
CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX
US Market

CNBX Pharmaceuticals (CNBX) Income Statement

Compare
122 Followers

CNBX Pharmaceuticals Income Statement

Last quarter (Q3 2025), CNBX Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, CNBX Pharmaceuticals's net income was $-59.73K. See CNBX Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 130.07K$ 410.17K$ 29.96K$ 0.00
Gross Profit
$ 0.00$ 130.07K$ 410.17K$ -169.00K$ -221.00K
Operating Expenses
$ 271.69K$ 713.21K$ 1.34M$ 2.79M$ 2.60M
Depreciation and Amortization
$ 0.00$ 72.32K$ 162.06K$ 198.53K$ 220.93K
EBITDA
$ -271.69K$ -603.00K$ -3.55M$ -3.52M$ -2.91M
Operating Income
$ -271.69K$ -583.00K$ -931.00K$ -2.95M$ -2.60M
Other Income/Expenses
$ -42.28K$ -112.00K$ -2.78M$ -1.39M$ -594.00K
Pretax Income
$ -313.98K$ -695.00K$ -3.71M$ -4.35M$ -3.19M
Net Income
$ -313.98K$ -695.00K$ -3.71M$ -3.72M$ -3.19M
Per Share Metrics
Basic EPS
$ 0.00$ -0.02$ -0.42$ -3.59$ -2.16
Diluted EPS
$ 0.00$ -0.02$ -0.42$ -3.59$ -2.16
Weighted Average Shares Outstanding
90.65M 30.25M 8.82M 1.22M 1.15M
Weighted Average Shares Outstanding (Diluted)
90.65M 30.25M 8.82M 1.22M 1.15M
Currency in USD

CNBX Pharmaceuticals Earnings and Revenue History